Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
01/2011
01/12/2011EP2272827A1 Sulphonylpyrroles as hdac inhibitors
01/12/2011EP2272825A2 N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation
01/12/2011EP2272813A2 Copper-catalyzed formation of carbon-oxygen bonds
01/12/2011EP2272516A2 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor
01/12/2011EP2272513A1 Pharmaceutical compositions for treating cancer
01/12/2011EP2272512A1 Pharmaceutical compositions for treating cancer
01/12/2011EP2271641A1 Fungicide hydroximoyl-heterocycles derivatives
01/12/2011EP2271640A2 Piperidine derivatives as cgrp receptor antagonists
01/12/2011EP2271639A2 Fungicide hydroximoyl-tetrazole derivatives
01/12/2011EP2271632A1 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as hdl-cholesterol raising agents
01/12/2011EP2271631A2 Inhibitors of protein kinases
01/12/2011EP2271629A1 Substituted pyrimidin-5-carboxamides 281
01/12/2011EP2271626A1 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
01/12/2011EP2271625A2 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
01/12/2011EP2271619A1 Compounds and compositions as modulators of gpr119 activity
01/12/2011EP2271338A1 Method for treating neurological disorders with imidazolium and imidazolinium compounds
01/12/2011EP1987006B1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
01/12/2011EP1943242B1 Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists
01/12/2011EP1869015B1 An improved process for the manufacture of rabeprazole sodium
01/12/2011EP1682138B1 Heterocyclic inhibitors of mek
01/12/2011EP1670784B1 Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists
01/12/2011EP1560580B1 Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors
01/12/2011CN101945879A Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates
01/12/2011CN101945857A High dielectric constant liquid crystal
01/12/2011CN101945856A Herbicidal pyridazinone derivatives
01/12/2011CN101945851A Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors
01/12/2011CN101941973A Benzoglioxaline-4-amide type derivative, preparation method, medical composition and application thereof
01/12/2011CN101941964A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
01/12/2011CN101941948A Histone deacetylase inhibitor with branched structure and synthesized through click chemistry
01/12/2011CN101941941A Carboxylic ester compound and applications thereof
01/12/2011CN101941917A Amide compounds and use thereof
01/12/2011CN101584694B Peptide deformylase inhibitor containing 2, 5-dihydropyrrole and synthesizing method
01/12/2011CN101029022B Process for the preparation of 4-phenoxy quinoline derivatives
01/11/2011US7868225 Artichoke hybrid named ‘PS-H2015’
01/11/2011US7868204 Inhibitors of histone deacetylase
01/11/2011US7868178 4-Phenoxy-, 4-phenylthio-, 4-phenylsulfonyl- or 5-phenylsulfinyl-1-(2-pyridinyl)pyrrolidene derivatives; e.g. 3-[4-(trifluoromethyl)phenoxy]-1-[5-(trifluoromethyl)-2-pyridyl]pyrrolidine insecticides, miticides and nematocides
01/11/2011US7868177 protein kinase inhibitors such as N-(4-((3-(2-(methylamino)-4-pyrimidinyl)-2-pyridinyl)oxy)-1-naphthalenyl)-1H-benzimidazol-2-amine, used for the treatment of breast cancer or rheumatoid arthritis; anticarcinogenic agents; antiarthritic agents
01/11/2011US7868175 Biphenyl compounds useful as muscarinic receptor antagonists
01/11/2011US7868174 Form of a benzenesulfonamide derivative
01/11/2011US7868172 2-(hetero)-aryl substituted tetrahydroquinoline derivatives
01/11/2011US7868171 N-alkoxy-4, 4-dioxy-polyalkyl-piperidines as radical polymerization initiators
01/11/2011US7868036 Renin inhibitors; hypertension, heart failure, glaucoma, myocardial infarction, kidney failure or restenosis; broad group of compounds that are hydroxy-functional diamines such as 3-Amino-1-isopropylamino-5-[3-(3-methoxypropyl)-1-methyl-1H-indol-5-ylmethyl]-6-methylheptan-2-ol dihydrochloride
01/11/2011US7868034 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
01/11/2011US7868024 vanilloid receptor antagonists such as N-(1,2-Dimethyl-1H-benzimidazol-5-yl)-5-fluoro-1-(4,6-dimethylpyridin-2-yl)-1H-indole-2-carboxamide, used for the treatment of inflammation, psoriasis, pruritus, herpes, shingles, multiple sclerosis, metabolic, gastrointestinal and respiratory system disorders
01/11/2011US7868021 Antimicrobial quinolones, their compositions and uses
01/11/2011US7868014 1-(hetero)aryl-3-amino-pyrrolidine derivatives for use as mGluR3 antagonists
01/11/2011US7868013 Cycloalkyl substituted pyrimidinediamine compounds and their uses
01/11/2011US7868008 Substituted isoindolones and their use as metabotropic glutamate receptor potentiators
01/11/2011US7868005 Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity
01/11/2011US7867949 Hydrazide compound and pesticidal use of the same
01/11/2011US7867629 2,4-Diphenyl-6-(10-phenyl-anthracen-9-yl-pyrimidine; achieves elevation of luminance; excellent efficiency of light emission; long lifetime by an improvement of an electrode adhesion; durability; stability; OLED/organic light emitters
01/11/2011US7867330 Method for composing a nano-particle metal treatment composition for creating a ceramic-metal layer
01/11/2011CA2536384C Cyclic derivatives as modulators of chemokine receptor activity
01/11/2011CA2534088C 2,3-substituted pryidl compounds useful for treating pain
01/11/2011CA2492138C N-phenyl-(2r,5s)dimethylpiperazine derivative
01/11/2011CA2456426C New mandelic acid derivatives and their use as thrombin inhibitors
01/11/2011CA2453974C 4-(benzylideneamino)-3-(methylsulfanyl)-4h-1,2,4-triazin-5-one derivatives having a pde iv-inhibiting and tnf-antagonistic action for the treatment of heart diseases and allergies
01/11/2011CA2453445C Pyridin-2-yl-methlyamine derivatives for treating opioid dependence
01/11/2011CA2436891C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
01/11/2011CA2411778C Organic compounds
01/11/2011CA2407593C Fused heteroaryl derivatives
01/11/2011CA2387095C Compound with growth hormone releasing properties
01/11/2011CA2385592C Benzamides and related inhibitors of factor xa
01/06/2011WO2011002984A1 Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligands
01/06/2011WO2011002408A1 Novel compounds for treatment of neurodegeneration associated with diseases, such as alzheimer's disease or dementia
01/06/2011WO2011002407A1 Novel compounds for treatment of neurodegeneration associated with diseases, such as alzheimer's disease or dementia
01/06/2011WO2011002067A1 Heterocyclic compound and use thereof
01/06/2011WO2011001088A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
01/06/2011WO2011000915A1 Isoform-selective hcn blockers
01/06/2011WO2010118711A3 Novel helquats, their precursors and method of preparation thereof
01/06/2011WO2009066321A3 Process for optically active sulfoxide compounds
01/06/2011US20110003998 Process for preparing 2-amino-5-cyanobenzoic acid derivatives
01/06/2011US20110003996 Crystal Forms of (3R)-1-(2-Methylalanyl-D-Tryptophyl)-3-(Phenylmethyl)-3-Piperidinecarboxylic Acid 1,2,2-Trimethylhydrazide
01/06/2011US20110003994 Cycloalkane derivative
01/06/2011US20110003991 Piperazine derivatives and their use in controlling pests
01/06/2011US20110003862 3-Animopyraolines for Treatment of Neurodegenerative and Psychiatric Diseases
01/06/2011US20110003859 N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer
01/06/2011US20110003858 Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors
01/06/2011US20110003853 Metalloproteinase Inhibitors
01/06/2011US20110003852 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
01/06/2011US20110003851 Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors
01/06/2011US20110003845 Substituted azabicyclic compounds and the use thereof
01/06/2011US20110003839 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
01/06/2011US20110003836 Pro-Neurogenic Compounds
01/06/2011US20110003833 Novel aminopyridine derivatives having aurora a selective inhibitory action
01/06/2011US20110003829 Enrofloxacin hexahydrate
01/06/2011US20110003828 Prodrugs of nh-acidic compounds
01/06/2011US20110003826 Anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution
01/06/2011US20110003825 Substituted amide beta secretase inhibitors
01/06/2011US20110003817 Whitening Agent And Skin External Preparation
01/06/2011US20110003815 Diphenyl substituted cycloalkanes
01/06/2011US20110003814 Pyrimidines useful as modulators of voltage-gated ion channels
01/06/2011US20110003813 Substituted biaryl piperazinyl-pyridine analogues
01/06/2011US20110003812 Human Adam-10 Inhibitors
01/06/2011US20110003808 Octahydroquinolizines for antidiabetic treatment
01/06/2011US20110003799 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
01/06/2011US20110003797 HEXAHYDROCYCLOPENTYL[f]INDAZOLE CARBOXAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
01/06/2011US20110003794 Naphthyridine Integrase Inhibitors
01/06/2011US20110003759 Non-basic melanin concentrating hormone receptor-1 antagonists and methods
01/06/2011US20110003690 Insecticidal arylpyrrolines